Son d\u00f6nemde diyabet tedavisi ve kilo kontrol\u00fc amac\u0131yla kullan\u0131lan semaglutid etken maddesi i\u00e7eren ila\u00e7larla ilgili \u201cani g\u00f6rme kayb\u0131\u201d iddialar\u0131 kamuoyunda tart\u0131\u015fma konusu oldu. \u0130\u00e7 Hastal\u0131klar\u0131 Uzman\u0131 Dr. Burak Uzel, konuyla ilgili yap\u0131lan bilimsel ara\u015ft\u0131rmalar\u0131n sonu\u00e7lar\u0131na ili\u015fkin a\u00e7\u0131klama yapt\u0131.<\/p>\n
Dr. Uzel, \u00e7al\u0131\u015fmalar\u0131n semaglutid kullan\u0131m\u0131n\u0131n \u201ciskemik optik n\u00f6ropati\u201d olarak adland\u0131r\u0131lan g\u00f6rme siniri hasar\u0131 riskini art\u0131rabilece\u011fini g\u00f6sterdi\u011fini belirtti. Ara\u015ft\u0131rma verilerine g\u00f6re semaglutid kullanan 100 bin diyabet hastas\u0131n\u0131n yakla\u015f\u0131k 70\u2019inde be\u015f y\u0131l i\u00e7inde bu durumun geli\u015fti\u011fi g\u00f6zlemlendi.<\/p>\n
Uzel, ilac\u0131 kullanmayan yakla\u015f\u0131k 300 bin diyabet hastas\u0131nda ise benzer tablonun 150 ki\u015fide g\u00f6r\u00fcld\u00fc\u011f\u00fcn\u00fc ifade ederek, s\u00f6z konusu verilerin riskte art\u0131\u015fa i\u015faret etti\u011fini ancak toplam olas\u0131l\u0131\u011f\u0131n d\u00fc\u015f\u00fck seviyede kald\u0131\u011f\u0131n\u0131 s\u00f6yledi.<\/p>\n
Riskin baz\u0131 hasta gruplar\u0131nda daha y\u00fcksek olabilece\u011fini belirten Dr. Uzel, g\u00f6z dibi muayenesinde k\u00fc\u00e7\u00fck optik disk yap\u0131s\u0131na sahip bireylerin, 50 ya\u015f ve \u00fczerindeki ki\u015filerin ile uyku apnesi ve kontrols\u00fcz hipertansiyonu bulunan hastalar\u0131n daha dikkatli takip edilmesi gerekti\u011fini kaydetti.<\/p>\n
Dr. Uzel ayr\u0131ca, ila\u00e7 kullan\u0131ls\u0131n ya da kullan\u0131lmas\u0131n \u00f6zellikle sabah saatlerinde fark edilen tek tarafl\u0131 ani g\u00f6rme kayb\u0131 durumunda vakit kaybetmeden bir g\u00f6z hastal\u0131klar\u0131 uzman\u0131na ba\u015fvurulmas\u0131n\u0131n \u00f6nem ta\u015f\u0131d\u0131\u011f\u0131n\u0131 ifade etti.<\/p>\n
<\/strong> \u0130stanbul, 11 Mart (Hibya) – \u0130\u00e7 Hastal\u0131klar\u0131 Uzman\u0131 Dr. Burak Uzel, semaglutid etken maddesi i\u00e7eren ve diyabet ile kilo kontrol\u00fc amac\u0131yla kullan\u0131lan ila\u00e7larla ilgili g\u00fcndeme gelen \u201cani g\u00f6rme kayb\u0131\u201d iddialar\u0131na ili\u015fkin bilimsel verileri payla\u015ft\u0131.<\/p>\n","protected":false},"author":1,"featured_media":59616,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"googlesitekit_rrm_CAow07ekDA:productID":"","footnotes":""},"categories":[4],"tags":[],"class_list":["post-59615","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-dunya"],"_links":{"self":[{"href":"https:\/\/ekonomigundemi.com.tr\/index.php\/wp-json\/wp\/v2\/posts\/59615","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/ekonomigundemi.com.tr\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/ekonomigundemi.com.tr\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/ekonomigundemi.com.tr\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/ekonomigundemi.com.tr\/index.php\/wp-json\/wp\/v2\/comments?post=59615"}],"version-history":[{"count":0,"href":"https:\/\/ekonomigundemi.com.tr\/index.php\/wp-json\/wp\/v2\/posts\/59615\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/ekonomigundemi.com.tr\/index.php\/wp-json\/wp\/v2\/media\/59616"}],"wp:attachment":[{"href":"https:\/\/ekonomigundemi.com.tr\/index.php\/wp-json\/wp\/v2\/media?parent=59615"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/ekonomigundemi.com.tr\/index.php\/wp-json\/wp\/v2\/categories?post=59615"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/ekonomigundemi.com.tr\/index.php\/wp-json\/wp\/v2\/tags?post=59615"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nEKONOM\u0130 GAZETES\u0130 <\/p>\n","protected":false},"excerpt":{"rendered":"